Cybertrust Achieves Cross-Certification with SAFE(TM) Digital Identity Standard
Share:
As First Cross-Certified Information Security Company, Cybertrust Continues its Leadership and Commitment to SAFE-BioPharma Association
HERNDON, Va., April 18 / -- SAFE-BioPharma Association today announced that Cybertrust(R), the global information security specialist, has officially become the first information security company to be cross-certified with the SAFE(TM) Bridge Certificate Authority. In addition, Cybertrust is the first organization, along with Johnson & Johnson Services, to attain cross-certification. Achieving cross-certification allows Cybertrust to offer additional services to its customers who are SAFE members, such as the ability to offer SAFE digital identity credentials and SAFE authentication and digital signature services.
The mission of SAFE is to deliver unique electronic identity credentials for legally enforceable and regulatory compliant digital signatures across the global bio-pharmaceutical environment. The SAFE credential supports business-to-business, and business to regulator transactions. The SAFE standard is a secure, reliable means of communicating and executing transactions over public and private networks between mission-critical applications.
"Cybertrust is helping the healthcare industry achieve a common method of identity assurance, transforming the way it does business," said Mollie Shields-Uehling, president and CEO, SAFE-BioPharma Association. "As the first company to be cross-certified with the SAFE standard, Cybertrust is simplifying the process for SAFE members to efficiently and securely collaborate across the industry. Cybertrust's leadership will facilitate the widespread exchange and acceptance of SAFE-signed electronic transmissions."
"Cybertrust has been involved with SAFE since its inception, and is proud to continue our work with SAFE and its members to expand the scope of services available to the community and to grow the value of the SAFE credential," said Tom Greco, Cybertrust vice president of enabling infrastructures. "Achieving cross-certification will allow us to provide SAFE members and our customers with additional services to help them achieve simplified, secure, and streamlined business-to-business and business-to-regulatory information exchange."
Cybertrust currently hosts the SAFE BioPharma Bridge Certificate Authority, which provides SAFE with the technical and operational system to facilitate the interoperability of SAFE credentials. As a SAFE Issuer, Cybertrust can supply credential issuance and validation services to those members of the SAFE community who have not established that capability themselves.
For more information about Cybertrust and SAFE, please visit http://www.cybertrust.com/solutions/identity_management/safe_im.
About Cybertrust
Cybertrust is the global information security specialist, delivering services that secure critical data, protect identities and help customers demonstrate ongoing compliance. Headquartered in Herndon, Virginia, USA with more than 30 offices around the globe, Cybertrust is one of the world's largest providers of information security and is recognized as the global market leader in managed security services. For more information, visit http://www.cybertrust.com/.
About SAFE-BioPharma Association
The SAFE(TM) (Signatures and Authentication For Everyone) digital identity standard facilitates both strong authentication and the creation of digital signatures. It was developed with the specific goal of achieving interoperability in a secure and trusted environment within the pharmaceutical and healthcare industries.
The SAFE standard provides a secure, enforceable, and regulatory compliant way to verify the identities of parties involved in business-to-business and business-to-regulator electronic transactions.
SAFE-BioPharma Association developed and manages the SAFE digital standard. The Association's founder-members include AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Johnson & Johnson, Merck, Pfizer, Procter & Gamble, and Sanofi-Aventis. The organization became operational in 2005. For more information, visit http://www.safe-biopharma.org/.
Cybertrust is a trademark or registered trademark of Cybertrust Holdings, Inc. and/or its affiliates. All other trademarks are property of their respective owners.
SAFE(TM) is a trademark of SAFE-BioPharma Association. Any use of this trademark requires approval from SAFE-BioPharma Association.
Source: Cybertrust
Contacts:
Laura Wooster Amy Anderson
Cybertrust SHIFT Communications
+1 703.480.8535 +1 617.681.1225
laura.wooster@cybertrust.comaanderson@shiftcomm.com
CONTACT: Laura Wooster of Cybertrust, +1-703-480-8535,
laura.wooster@cybertrust.com; or Amy Anderson of SHIFT Communications,
+1-617-681-1225, aanderson@shiftcomm.com
Web site: http://www.cybertrust.com/
http://www.safe-biopharma.org/
